Hanna Lawnicka Selected Research

CGP 52608

6/2006	Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells.
5/2003	Melatonin inhibits growth of diethylstilbestrol-induced prolactin-secreting pituitary tumor in vitro: possible involvement of nuclear RZR/ROR receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanna Lawnicka Research Topics

Disease

17	Neoplasms (Cancer) 03/2020 - 04/2002
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016 - 06/2006
4	Pituitary Neoplasms (Pituitary Adenoma) 01/2012 - 05/2003
3	Colonic Neoplasms (Colon Cancer) 01/2012 - 01/2007
2	Thyroid Neoplasms (Thyroid Cancer) 03/2020 - 04/2010
2	Goiter 03/2020 - 04/2010
2	Vitamin D Deficiency 02/2018 - 01/2016
2	Carcinoid Tumor (Carcinoid) 08/2014 - 06/2006
2	Carcinogenesis 04/2010 - 09/2007
2	Adenoma (Adenomas) 01/2009 - 11/2007
2	Prolactinoma (Prolactinomas) 11/2007 - 09/2006
2	Graves Ophthalmopathy 06/2007 - 01/2007
1	follicular Thyroid cancer 03/2020
1	Papillary Thyroid Cancer 03/2020
1	Anaplastic Thyroid Carcinoma 03/2020
1	Hypothyroidism 02/2018
1	medullary Thyroid cancer 08/2014
1	Paraganglioma (Paragangliomas) 01/2013
1	Pheochromocytoma 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Adrenocortical Carcinoma 05/2010
1	Small Cell Carcinoma 09/2008
1	Colorectal Neoplasms (Colorectal Cancer) 09/2007
1	Autoimmune Diseases (Autoimmune Disease) 06/2007
1	Inflammation (Inflammations) 01/2007
1	Graves Disease (Basedow Disease) 01/2007
1	Breast Neoplasms (Breast Cancer) 06/2006
1	Glucagonoma 06/2006
1	Vipoma (WDHA) 06/2006

Drug/Important Bio-Agent (IBA)

8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 09/2006
4	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2012 - 09/2008
4	MelatoninIBA 01/2009 - 04/2002
3	CytokinesIBA 03/2020 - 06/2007
3	hydroxide ionIBA 02/2018 - 04/2010
3	Vitamin D FDA LinkGeneric 02/2018 - 04/2010
3	AngiotensinsIBA 08/2012 - 11/2007
2	RacivirIBA 03/2020 - 04/2010
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2016 - 06/2006
2	MTOR InhibitorsIBA 08/2014 - 01/2013
2	Semaxinib (SU5416)IBA 08/2014 - 01/2013
2	EndostatinsIBA 08/2014 - 01/2013
2	Sirolimus (Rapamycin)FDA Link 08/2014 - 01/2013
2	Interferon-alpha (Interferon Alfa)IBA 08/2014 - 01/2013
2	Peptides (Polypeptides)IBA 08/2012 - 11/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012 - 01/2010
2	Growth Hormone (Somatotropin)IBA 01/2012 - 09/2008
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 01/2012
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2009 - 05/2003
2	Melatonin Receptors (Melatonin Receptor)IBA 01/2009 - 04/2002
2	Diethylstilbestrol (Stilbestrol)FDA Link 11/2007 - 05/2003
2	Fluorouracil (Carac)FDA LinkGeneric 09/2007 - 01/2007
2	Bromodeoxyuridine (BrdU)IBA 09/2007 - 04/2002
2	Troleandomycin (TAO)FDA Link 06/2007 - 01/2007
2	Pharmaceutical PreparationsIBA 01/2007 - 09/2006
2	ProlactinIBA 09/2006 - 05/2003
2	Estrogens (Estrogen)FDA Link 09/2006 - 06/2006
2	CGP 52608IBA 06/2006 - 05/2003
2	LigandsIBA 06/2006 - 04/2002
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2020
1	Angiogenesis InhibitorsIBA 08/2014
1	TOR Serine-Threonine KinasesIBA 01/2013
1	AT4 receptorIBA 08/2012
1	Ghrelin ReceptorsIBA 01/2012
1	somatotropin releasing hormone receptorIBA 01/2012
1	Dihydrotachysterol (AT 10)IBA 01/2012
1	GhrelinIBA 01/2012
1	Insulin-Like PeptidesIBA 01/2012
1	p38 Mitogen-Activated Protein KinasesIBA 01/2012
1	Angiopoietin-2IBA 01/2012
1	Phosphotransferases (Kinase)IBA 05/2010
1	Casein Kinase II (Casein Kinase 2)IBA 05/2010
1	Protein Kinases (Protein Kinase)IBA 05/2010
1	Calcifediol (Calcidiol)FDA Link 04/2010
1	Cholecalciferol (Vitamin D3)FDA Link 04/2010
1	CalciumIBA 04/2010
1	Sermorelin (Sermorelin Acetate)FDA Link 10/2009
1	Chromogranin AIBA 10/2009
1	Hormones (Hormone)IBA 10/2009
1	luzindoleIBA 01/2009
1	JV 1-36IBA 09/2008
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2007
1	SteroidsIBA 09/2007
1	Selective Estrogen Receptor Modulators (SERM)IBA 09/2007
1	Tamoxifen FDA LinkGeneric 09/2007
1	Monoclonal AntibodiesIBA 06/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007
1	Infliximab (Remicade)FDA Link 01/2007
1	LeptinIBA 01/2007
1	Thalidomide (Thalomid)FDA Link 09/2006
1	glutarimideIBA 09/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2006
1	2,4-thiazolidinedione (thiazolidinedione)IBA 06/2006
1	pentetreotide (OctreoScan)FDA Link 06/2006
1	lanreotide (Somatuline)FDA Link 06/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 06/2006
1	Radioisotopes (Radionuclides)IBA 06/2006
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2006
1	Methotrexate (Mexate)FDA LinkGeneric 06/2006

Therapy/Procedure

5	Therapeutics 01/2016 - 06/2006
1	Drug Therapy (Chemotherapy) 09/2007